You are here

Lobe Sciences Ltd.

Lobe Sciences Ltd.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
LOBE
CSE Index: 
Currency: 

The Company is working to develop psychedelic compounds as therapeutics. Initially the Company will develop psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of these medications. The Company also owned acquired brands, intellectual property and leases office and production premises to a cannabis processor and retailer which were disposed of on March 5, 2021.

You are here

Lobe Sciences Ltd. (LOBE)

SEDAR Information

Company Info

Address
Suite 1400-1199 West Hastings Street
Vancouver, BC V6E 3T5
Canada
Phone
1-949-505-5623
Email
info@lobesciences.com
Website
http://www.lobesciences.com
Listing date
Friday, June 7, 2019

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
38,300,147
Reserved for Issuance: 
10,336,484

Bulletins

09/06/2022

2022-0613 – Consolidation - Lobe Sciences Ltd. (LOBE)

le 9 juin/June 2022

Lobe Sciences Ltd. (the "Issuer") has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every six (6) pre-consolidated common shares.

As a result, the outstanding common shares of the Issuer will be reduced to approximately 38,230,000 common shares.

Advertisement

Publicité

Latest CSE News

Upcoming Events

cse_v2.png

27th Annual CSTA Conference

Thursday, August 18, 2022 - 1:30pm to Sunday, August 21, 2022 - 11:00am